TransMedics Raising $25 Million

TransMedics Inc., an Andover, Mass.–based medical device company focused on organ transplant technologies, is raising up to $25 million in Series D funding, according to a speech given yesterday by company CEO Waleed Hassanein at the Cowen & Co. Healthcare Conference. The news was first reported by VentureWire. Transmedics then would plan to go public. The company previously raised around $63 million in VC funding from firms like 3i Group, Alta Partners, CDP Capital, Flagship Ventures, JPMorgan Partners, Sherbrooke Capital Partners and VantagePoint Venture Partners.